NuVasive, Inc. (NUVA) Financial Analysis & Valuation | Quarter Chart
NuVasive, Inc. (NUVA)
NUVAPrice: $39.75
Fair Value: 🔒
🔒score
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruptio... more
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions... more
Description
Shares
| Market Cap | $2.08B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | J. Christopher Barry |
| IPO Date | 2004-05-13 | CAGR | 0.58% |
| Employees | 3,000 | Website | www.nuvasive.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.15% | Total Yield | 0.15% |
NUVA chart loading...
Fundamentals
Technicals
| Enterprise Value | $3.01B | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.73 | P/B Ratio | 2.62 |
| P/CF Ratio | 13.48 | P/FCF Ratio | 70.22 |
| EPS | $0.53 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | -36.38% |
| Revenue Growth 1Y | 4.44% | Gross Margin | 0.72% |
| Operating Margin | 0.05% | Profit Margin | 0.03% |
| ROE | 0.05% | ROA | 0.02% |
| ROCE | 0.04% | Current Ratio | 1.21 |
| Quick Ratio | 0.74 | Cash Ratio | 0.35 |
| Debt/Equity | 1.16 | Interest Coverage | 3.72 |
| Altman Z Score | 1.86 | Piotroski Score | 7 |